Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets

Glenmark Pharmaceuticals on Wednesday said it has received tentative
approval from the US health regulator for its generic Dapagliflozin
and Saxagliptin anti-diabetes tablets.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-tentative-usfda-nod-for-generic-anti-diabetes-tablets/articleshow/75444093.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment